Everything You Need to Know about Viva Biotech 2022 Annual Results

News

}

Home / News / Company News / Company News detail

Time: 2023-03-30

Source: Viva Biotech

[Abstract]:Viva Biotech continues to increase the cross-promotion between biology and chemistry businesses and strengthen the construction of a one-stop drug R&D and manufacturing service platform, deepen the synergy between CRO and CDMO business, and actively build an open cooperation platform and win-win ecosystem for biomedical innovators around the world.

Previous Page：Viva Insights：CADD/AIDD—Accelerate the Process of Innovative Drug R&D Next Page：Viva Biotech Announced 2022 Annual Results

Back

Media contact: vivapr@vivabiotech.com

This site uses cookies and your privacy choices are important to us

We use cookies to improve the user experience and to analyze website traffic. By clicking "Accept", you consent to the use of cookies on our website, such as cookies policies.